TITLE

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer Il/core promoter/precore regions and HBV DNA levels

AUTHOR(S)
Yuen, M-F; Tanaka, Y.; Shinkai, N.; Poon, R. T.; But, D. Yiu-Kuen; Fong, D Y-T; Fung, J; Ka-Ho Wang, D; Chi-Hang Yuen, J; Mizokami, M; Lai, C-L
PUB. DATE
January 2008
SOURCE
Gut;Jan2008, Vol. 57 Issue 1, p98
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background/aim: To examine the risks for hepatocellular carcinoma (HCC) with respect to hepatitis B virus (HBV) genotypes, specific viral mutations (MT), serum HBV DNA levels, and cirrhosis. Methods: HBV genotypes, 1653/1753/core promoter (CP)/precore MT and HBV DNA levels were determined in 248 HBV patients with HCC and 248 HBV controls. Results: Genotype C, CP-MT, T1653, HBV DNA levels ⩾4 log10 copies/ml and cirrhosis had a higher risk for HCC compared to patients with genotype B (p = 0.001, OR 1.9), CP wild-type (WT) (p<0.001, OR 4.1), C1653 (p = 0.028, OR 2.4), HBV DNA <4 log10 copies/ml (p = 0.003, OR 2.1) and without cirrhosis (p<0.001, OR 4.0) respectively. Multivariate analysis showed that CP-MT, T1653, HBV DNA ⩾4 log10 copies/ml and cirrhosis were independent factors for HCC (all p<0.05). A receiver operating characteristics curve showed no cut-off HBV DNA level associated with minimal chance of HCC. Patients with CP-MT and cirrhosis had a 22.2-fold increased risk of HCC compared to patients with CP-WT and without cirrhosis. Patients with CP-MT and HBV DNA levels ⩾4 log10 copies/ml had a 7.2-fold increased risk of HCC compared to patients with CP-WT and HBV DNA levels <4 log10 copies/ml. Patients with CP-MT and T1653 had a 9.9-fold increased risk of HCC compared to patients with wild-type for both regions. Conclusions: CP-MT, T1653, HBV DNA levels ⩾4 log10 copies/ml and cirrhosis are independent factors for development of HCC. The risks increased substantially in patients having these factors in combination.
ACCESSION #
28718677

 

Related Articles

  • Predicting the development of hepatocellular cancer in hepatitis B carriers. de Mitri, M.S.; Bernardi, M. // Gut;Jan2008, Vol. 57 Issue 1, p12 

    The article reflects on predicting hepatocellular cancer (HCC) development in hepatitis B virus (HBV) carriers. Association between cirrhosis and CC suggests that increased liver cell turnover caused by chronic liver injury and regeneration is the common pathway for hepatocarcinogenesis. Another...

  • Hepatocellular Carcinoma.  // Clinical Infectious Diseases;5/1/2006, Vol. 42 Issue 9, following pe78 

    The article reports that the risk of development of cirrhosis and of hepatocellular carcinoma increases in patients with chronic hepatitis B virus (HBV) infection. The risk for the development of hepatocellular carcinoma begins to increase when HBV DNA level starts increasing alarmingly. It also...

  • Low Genetic Diversity despite Hyperendemicity of Hepatitis B Virus Genotype E throughout West Africa.  // Journal of Infectious Diseases;7/15/2004, Vol. 190 Issue 2, p400 

    The article discusses several aspects of the hepatitis B virus genotypes at the Sub-Saharan Africa. Topic discussed include the viral DNA; chronic liver diseases, such as cirrhosis and hepatocellular carcinoma; and genomic mutations. In addition, reference is made the viral polymerase, and...

  • Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis V Virus.  // JAMA: Journal of the American Medical Association;1/4/2006, Vol. 295 Issue 1, p65 

    t: Serum hepatitis B virus (HBV) DNA level is a marker of viral replication and efficacy of antiviral treatment in individuals with chronic hepatitis B. Objective: To evaluate the relationship between serum HBV DNA level and risk of hepatocellular carcinoma. Design, Setting, and Participants:...

  • Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma. Liu, Jessica; Hwai-I Yang; Mei-Hsuan Lee; Sheng-Nan Lu; Chin-Lan Jen; Batrla-Utermann, Richard; Li-Yu Wang; San-Lin You; Chuhsing K. Hsiao; Pei-Jer Chen; Chien-Jen Chen // Gut;Oct2014, Vol. 63 Issue 10, p1648 

    Background and aims The associations between long-term risk of hepatocellular carcinoma (HCC) and spontaneous seroclearance of HBV e antigen (HBeAg), HBV DNA and HBV surface antigen (HBsAg) have never been examined by a prospective study using serially measured seromarkers. This study aimed to...

  • Combined Mutations in Pre-S/Surface and Core Promoter/Precore Regions of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma: A Case-Control Study. Chien-Hung Chen; Chi-Sin Changchien; Chuan-Mo Lee; Chao-Hung Hung; Tsung-Hui Hu; Jing-Houng Wang; Jyh-Chwan Wang; Sheng-Nan Lu // Journal of Infectious Diseases;12/1/2008, Vol. 198 Issue 11, p1634 

    Background. We sought to investigate the role of sequence variations in pre-S/surface and basal core promoter (BCP)/precore regions of the hepatitis B virus (HBV) in hepatocellular carcinoma (HCC). Methods. The direct sequencing in pre-S/surface and BCP/precore regions of HBV was determined for...

  • Reasons to consider earlier treatment of chronic HBV infections. Zoulim, Fabien; Mason, William S. // Gut;Mar2012, Vol. 61 Issue 3, p333 

    The article discusses the reasons to consider earlier for the treatment of chronic hepatitis B virus (HBV) infections. It states that cirrhosis, liver failure and hepatocellular carcinoma (HCC) diseases are caused by the HBV infection which occur at the early stage of life. It also informs that...

  • Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis. Stroffolini, Tommaso; Almasio, Piero Luigi; Persico, Marcello; Bollani, Simona; Benvegn, Luisa; Di Costanzo, GiovanGiuseppe; Pastore, Giuseppe; Aghemo, Alessio; Stornaiuolo, Gianfranca; Mangia, Alessandra; Andreone, Pietro; Stanzione, Maria; Mazzella, Giuseppe; Saracco, Giorgio; Del Poggio, Paolo; Bruno, Savino // American Journal of Gastroenterology;Aug2008, Vol. 103 Issue 8, p1966 

    BACKGROUND: While the likelihood of developing hepatocellular carcinoma (HCC) in patients coinfected with both HBV and HCV is increased, the role of previous exposure to HBV as a risk factor associated with tumor occurrence in subjects with HCV-related cirrhosis has not been fully investigated....

  • Histological characteristics predisposing to development of hepatocellular carcinoma in patients with chronic hepatitis B. Sae Hwan Lee; Young-Hwa Chung; Kim, Jeong A.; Young-Joo Jin; Won Hyung Park; Jong Gi Choi; Danbi Lee; Ju Hyun Shim; Eunsil Yu; Myoung Kuk Jang // Journal of Clinical Pathology;Jun2011, Vol. 64 Issue 6, p599 

    Aims Longstanding liver inflammation leads to hepatic regeneration and fibrosis, which subsequently progresses to cirrhosis in some patients with chronic hepatitis B virus (HBV) infection. It remains unclear, however, if the histological severity of chronic hepatitis B (CHB) may determine the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics